332P Treatment-emergent (TE) neutropenia and related hospitalizations and medication discontinuations in patients (pts) with metastatic breast cancer (MBC) treated with palbociclib (PAL) or ribociclib (RIB): A real-world analysis
| Autor: | Schwartzberg, L., Kanakamedala, H., Thuerigen, A., Chandiwana, D., Yu, C-L., Balu, S., Turner, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S379-S379 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|